For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260219:nRSS6594Ta&default-theme=true
RNS Number : 6594T Clean Power Hydrogen PLC 19 February 2026
19 February 2026
Clean Power Hydrogen plc
("CPH2" or the "Company")
Investor Webinar 26 February 2026
CPH2 (AIM:CPH2), which has developed market disrupting and IP-protected
Membrane-Free Electrolyser ("MFE") technology for the production of commercial
high purity hydrogen and medical-grade oxygen, announces that Richard Scott
(Chief Commercial Officer) will be presenting an Investor Webinar at 6:00p.m.
(GMT) on 26 February 2026. The webinar is open to shareholders and other
interested parties and is hosted by the Company's joint broker, Turner Pope
Investments.
There will be a Q&A session for investors after the Company's
presentation, for which questions can be submitted pre-event as part of the
registration process.
To register for the webinar please us the link below:
https://www.turnerpope.com/register-cph2/
(https://www.turnerpope.com/register-cph2/)
The webinar will focus on how CPH2 is able to support existing users of high
purity hydrogen and medical grade oxygen with a proven and patented lower cost
solution than competitors. Unlike other operators, CPH2 is serving real-world
markets with current demand and can produce two high value commodities from
one modular on-site unit. With delivery of the first 1MW machine in sight,
Richard will discuss the many growing sectors the Company can now support.
ENDS
Enquiries:
Clean Power Hydrogen
plc
via Square 1
Jon Duffy, Chief Executive Officer
James Hobson, Chief Financial Officer
Cavendish Capital Markets Limited - NOMAD & Broker
Neil McDonald
+44 131
220 9771
Peter Lynch
+44 131 220 9772
Turner Pope Investments (TPI) Limited - Broker
Andy Thacker/Guy McDougall
+44 203 657 3657
Square1 Consulting Limited - Investor Relations
+44 7831 381201
David
Bick
Background on CPH2
CPH2 is the holding company of Clean Power Hydrogen Group Limited which has
almost a decade of dedicated research and product development experience. This
experience has resulted in the creation and proving of simple, safe and
sustainable technology which is designed to deliver a modular solution to the
hydrogen production market in a cost-effective, scalable, reliable and
long-lasting manner. The Group's strategic objective is to deliver the lowest
Levelised Cost of Hydrogen ("LCOH") in the market in relation to the
production of green hydrogen. CPH2 is listed on the AIM market and trades
under the ticker LSE: CPH2.
For more information: https://www.cph2.com (https://www.cph2.com/)
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAGLGDDUUBDGLC
Copyright 2019 Regulatory News Service, all rights reserved